AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy

被引：0
|
作者：
HQ Nguyen
F Okuku
F Ssewankambo
AS Magaret
C Johnston
A Wald
A Kambugu
L Corey
J Orem
C Casper
机构：
[1] University of Washington,Department of Epidemiology
[2] University of Washington,Department of Laboratory Medicine
[3] University of Washington,Deparment of Medicine
[4] Program in Biostatistics,undefined
[5] Fred Hutchinson Cancer Research Center,undefined
[6] Program in Vaccine and Infectious Disease Institute,undefined
[7] Fred Hutchinson Cancer Research Center,undefined
[8] Uganda Cancer Institute,undefined
[9] Infectious Disease Institute,undefined
来源：
Infectious Agents and Cancer | / 4卷 / Suppl 2期
关键词：
Lamivudine; Efavirenz; Nevirapine; Stavudine; Karnofsky Score;
D O I：
10.1186/1750-9378-4-S2-O5
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [1] Response of AIDS-associated Kaposi sarcoma to highly active antiretroviral therapy alone
    Paparizos, VA
    Kyriakis, KP
    Papastamopoulos, V
    Hadjivassiliou, M
    Stavrianeas, NG
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 30 (02) : 257 - 258
  • [2] The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma
    Dupin, N
    De Cervens, VR
    Gorin, I
    Calvez, V
    Pessis, E
    Grandadam, M
    Rabian, C
    Viard, JP
    Huraux, JM
    Escande, JP
    BRITISH JOURNAL OF DERMATOLOGY, 1999, 140 (05) : 875 - 881
  • [3] Influence of highly active antiretroviral therapy on the evolution of AIDS-associated Kaposi's sarcoma
    Alsina, MM
    Bulla, F
    Conill, C
    Mallolas, J
    Pérez-Cuevas, JB
    Lecha, M
    MEDICINA CLINICA, 2000, 115 (19): : 736 - 737
  • [4] A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy
    Stebbing, J
    Sanitt, A
    Nelson, M
    Powles, T
    Gazzard, B
    Bower, M
    LANCET, 2006, 367 (9521): : 1495 - 1502
  • [5] Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy
    Holkova, B
    Takeshita, K
    Cheng, DM
    Volm, M
    Wasserheit, C
    Demopoulos, R
    Chanan-Khan, A
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) : 3848 - 3851
  • [6] Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy
    Pellet, C
    Chevret, S
    Blum, L
    Gauvillé, C
    Hurault, M
    Blanchard, G
    Agbalika, F
    Lascoux, C
    Ponscarme, D
    Morel, P
    Calvo, F
    Lebbé, C
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (04) : 858 - 863
  • [7] Potential drug interaction with paclitaxel and highly active antiretroviral therapy in two patients with AIDS-associated Kaposi sarcoma
    Bundow, D
    Aboulafia, DM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (01): : 81 - 84
  • [8] Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: Implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma
    Krown, SE
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) : 399 - 402
  • [9] Rapamycin With Antiretroviral Therapy in AIDS-Associated Kaposi Sarcoma: An AIDS Malignancy Consortium Study
    Krown, Susan E.
    Roy, Debasmita
    Lee, Jeannette Y.
    Dezube, Bruce J.
    Reid, Erin G.
    Venkataramanan, Raman
    Han, Kelong
    Cesarman, Ethel
    Dittmer, Dirk P.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 (05) : 447 - 454
  • [10] Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy
    Miralles, P
    Berenguer, J
    Garcia de Viedma, D
    Padilla, B
    Cosin, J
    de Quirós, JCLB
    Muñoz, L
    Moreno, S
    Bouza, E
    AIDS, 1998, 12 (18) : 2467 - 2472
12345